Table II.

Study design for the bioequivalence evaluation of test^⁎ and reference^† azithromycin capsule formulations.

Study Period	Group	Azithromycin Formulation Administered
First	1	Two capsules (500-mg dose) of azithromycin reference formulation
	2	Two capsules (500-mg dose) of azithromycin test formulation
2-Week wash-out period
Second	1	Two capsules (500-mg dose) of azithromycin test formulation
	2	Two capsules (500-mg dose) of azithromycin reference formulation

^⁎Trademark: Ezill (Dr. Raza Pharma Pvt Ltd, Peshawar, Pakistan). Batch number 295, expiration 09/2011.

^†Trademark: Azomax (Novartis Pharma [Pakistan] Ltd, Karachi, Pakistan). Batch number J0003, expiration 05/2011.